DocuSign eSignature Enables Life Sciences to Comply with 21 CFR Part 11

When confronted by a health crisis, clinical research centers and institutes face manual regulatory document challenges that delay the operation of medical trials and delivery of treatments. To advance public health initiatives and streamline regulatory document processes, life science institutes need an FDA 21 CFR Part 11 compliant electronic signature solution that allows research teams to increase operational efficiency and productivity..

DocuSign Part 11 Module enables clinical and graduate research institutes to benefit from the electronic signature practices outlined in the FDA 21 CFR Part 11 regulation. In these resources, learn how higher education institutes and clinical organizations utilize DocuSign for consent, authorization, enrollment forms, purchase orders, and contract agreements all while complying with 21 CFR Part 11.